Publications

How Do Physical Activity and Exercise Affect Fabry Disease? Exploring a New Opportunity  (2024)

Authors:
Baciga, Federica; Marchi, Giacomo; Caccia, Federica; Momentè, Claudia; Esposito, Pasquale; Aucella, Filippo; Vitturi, Nicola; Pederzoli, Laura; Shakkour, Meilad; Granata, Antonio; Zicarelli, Maria Teresa; Girelli, Domenico; Andreucci, Michele; Carraro, Gianni; Battaglia, Yuri
Title:
How Do Physical Activity and Exercise Affect Fabry Disease? Exploring a New Opportunity
Year:
2024
Type of item:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Language:
Inglese
Referee:
No
Name of journal:
KIDNEY & BLOOD PRESSURE RESEARCH
ISSN of journal:
1420-4096
N° Volume:
49
Number or Folder:
1
Page numbers:
699-717
Keyword:
Anemia; Cardiac; Depression; Enzyme replacement therapy; Fabry disease; Lysosomal disease; Migalastat; Neurologic; Physical exercise; Psychosocial condition; Skeletal muscle
Short description of contents:
Background: Fabry disease (FD) is a multisystem, monogenic, X-linked storage disorder caused by mutations in the GLA gene, resulting in reduced alfa-galactosidase A enzyme activity. This effect leads to the accumulation of glycosphingolipids, particularly globotriaosylceramide, in various tissues, including the heart, kidney, vasculature, smooth muscle, and peripheral nervous system. Hemizygous males are usually more severely affected than females, in whom random inactivation of an X chromosome may lead to variable phenotype. Summary: Among the manifestations of FD, exercise intolerance is commonly diagnosed but often underestimated, even though it significantly limits quality of life, especially in young patients. This review primarily discusses the various pathophysiological mechanisms involved in exercise intolerance in FD patients, such as altered muscle composition, compromised cardiopulmonary framework, and peripheral neuropathy. Secondarily, it explores the potential effect of available therapy, including enzyme replacement therapy and chaperone therapy (migalastat), in reducing exercise intolerance while considering the potential impact of physical activity and exercise training as adjunctive treatments. Conclusion: Exercise intolerance has a major impact on the well-being of people with FD. Exercise training can play an important role in addition to drug therapy.
Product ID:
142695
Handle IRIS:
11562/1145513
Last Modified:
January 26, 2025
Bibliographic citation:
Baciga, Federica; Marchi, Giacomo; Caccia, Federica; Momentè, Claudia; Esposito, Pasquale; Aucella, Filippo; Vitturi, Nicola; Pederzoli, Laura; Shakkour, Meilad; Granata, Antonio; Zicarelli, Maria Teresa; Girelli, Domenico; Andreucci, Michele; Carraro, Gianni; Battaglia, Yuri, How Do Physical Activity and Exercise Affect Fabry Disease? Exploring a New Opportunity «KIDNEY & BLOOD PRESSURE RESEARCH» , vol. 49 , n. 12024pp. 699-717

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo IRIS

<<back

Activities

Research facilities

Share